APO RESEARCH · REPORT
Fungal Infection Diagnosis
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
Product & engineering
Understand the product.
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
Selected research
Industry Research
Fungal Infection Diagnosis Industry Research Report 2026
Market perspective
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019.
Read the full market overview
Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.
Report Scope
This report quantifies the global Fungal Infection Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Fungal Infection Diagnosis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fungal Infection Diagnosis Market by Company
ASSOCIATES OF CAPE COD
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A & C Biological Ltd.
Fungal Infection Diagnosis Segment by Type
Galactomannan Test
(1 to 3)-β-D-glucan Experiment
Fungal Infection Diagnosis Segment by Application
Hospital
Laboratory
Others
Fungal Infection Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Infection Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fungal Infection Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Infection Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Fungal Infection Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Galactomannan Test
- (1 to 3)-β-D-glucan Experiment
Applications
- Hospital
- Laboratory
- Others
Companies covered
- ASSOCIATES OF CAPE COD
- BioRad
- IMMY
- Beijing Jinshanchuan
- Danna Biological
- Zhanjiang A & C Biological Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Fungal Infection Diagnosis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Galactomannan Test
- 2.2.3 (1 to 3)-β-D-glucan Experiment
- 2.3 Fungal Infection Diagnosis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Fungal Infection Diagnosis Breakdown Data by Type
- 3.1 Global Fungal Infection Diagnosis Historic Market Size by Type (2021-2026)
- 3.2 Global Fungal Infection Diagnosis Forecasted Market Size by Type (2027-2032)
4 Fungal Infection Diagnosis Breakdown Data by Application
- 4.1 Global Fungal Infection Diagnosis Historic Market Size by Application (2021-2026)
- 4.2 Global Fungal Infection Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Fungal Infection Diagnosis Market Perspective (2021-2032)
- 5.2 Global Fungal Infection Diagnosis Growth Trends by Region
- 5.2.1 Global Fungal Infection Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Fungal Infection Diagnosis Historic Market Size by Region (2021-2026)
- 5.2.3 Fungal Infection Diagnosis Forecasted Market Size by Region (2027-2032)
- 5.3 Fungal Infection Diagnosis Market Dynamics
- 5.3.1 Fungal Infection Diagnosis Industry Trends
- 5.3.2 Fungal Infection Diagnosis Market Drivers
- 5.3.3 Fungal Infection Diagnosis Market Challenges
- 5.3.4 Fungal Infection Diagnosis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Fungal Infection Diagnosis Players by Revenue
- 6.1.1 Global Top Fungal Infection Diagnosis Players by Revenue (2021-2026)
- 6.1.2 Global Fungal Infection Diagnosis Revenue Market Share by Players (2021-2026)
- 6.2 Global Fungal Infection Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Fungal Infection Diagnosis Head Office and Area Served
- 6.4 Global Fungal Infection Diagnosis Players, Product Type & Application
- 6.5 Global Fungal Infection Diagnosis Manufacturers Established Date
- 6.6 Global Fungal Infection Diagnosis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Fungal Infection Diagnosis Market Size (2021-2032)
- 7.2 North America Fungal Infection Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Fungal Infection Diagnosis Market Size by Country (2021-2026)
- 7.4 North America Fungal Infection Diagnosis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Fungal Infection Diagnosis Market Size (2021-2032)
- 8.2 Europe Fungal Infection Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Fungal Infection Diagnosis Market Size by Country (2021-2026)
- 8.4 Europe Fungal Infection Diagnosis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Fungal Infection Diagnosis Market Size (2021-2032)
- 9.2 Asia-Pacific Fungal Infection Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Fungal Infection Diagnosis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Fungal Infection Diagnosis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Fungal Infection Diagnosis Market Size (2021-2032)
- 10.2 South America Fungal Infection Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Fungal Infection Diagnosis Market Size by Country (2021-2026)
- 10.4 South America Fungal Infection Diagnosis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Fungal Infection Diagnosis Market Size (2021-2032)
- 11.2 Middle East & Africa Fungal Infection Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Fungal Infection Diagnosis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Fungal Infection Diagnosis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ASSOCIATES OF CAPE COD
- 12.1.1 ASSOCIATES OF CAPE COD Company Information
- 12.1.2 ASSOCIATES OF CAPE COD Business Overview
- 12.1.3 ASSOCIATES OF CAPE COD Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.1.4 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio
- 12.1.5 ASSOCIATES OF CAPE COD Recent Developments
- 12.2 BioRad
- 12.2.1 BioRad Company Information
- 12.2.2 BioRad Business Overview
- 12.2.3 BioRad Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.2.4 BioRad Fungal Infection Diagnosis Product Portfolio
- 12.2.5 BioRad Recent Developments
- 12.3 IMMY
- 12.3.1 IMMY Company Information
- 12.3.2 IMMY Business Overview
- 12.3.3 IMMY Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.3.4 IMMY Fungal Infection Diagnosis Product Portfolio
- 12.3.5 IMMY Recent Developments
- 12.4 Beijing Jinshanchuan
- 12.4.1 Beijing Jinshanchuan Company Information
- 12.4.2 Beijing Jinshanchuan Business Overview
- 12.4.3 Beijing Jinshanchuan Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.4.4 Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio
- 12.4.5 Beijing Jinshanchuan Recent Developments
- 12.5 Danna Biological
- 12.5.1 Danna Biological Company Information
- 12.5.2 Danna Biological Business Overview
- 12.5.3 Danna Biological Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.5.4 Danna Biological Fungal Infection Diagnosis Product Portfolio
- 12.5.5 Danna Biological Recent Developments
- 12.6 Zhanjiang A & C Biological Ltd.
- 12.6.1 Zhanjiang A & C Biological Ltd. Company Information
- 12.6.2 Zhanjiang A & C Biological Ltd. Business Overview
- 12.6.3 Zhanjiang A & C Biological Ltd. Revenue in Fungal Infection Diagnosis Business (2021-2026)
- 12.6.4 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio
- 12.6.5 Zhanjiang A & C Biological Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst